Atomo Diagnostics Limited (ASX:AT1)

Market Cap	16.20M
Revenue (ttm)	4.22M
Net Income (ttm)	-6.45M
Shares Out	810.18M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,388,621
Average Volume	1,901,183
Open	0.0180
Previous Close	0.0200
Day's Range	0.0180 - 0.0200
52-Week Range	0.0140 - 0.0250
Beta	0.88
RSI	57.77
Earnings Date	Jul 31, 2025

About Atomo Diagnostics

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers rapid diagnostic test devices for HIV screening, pregnancy test, and respiratory test. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 85
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AT1

Financial Performance

In 2024, Atomo Diagnostics's revenue was 4.09 million, an increase of 60.65% compared to the previous year's 2.54 million. Losses were -6.85 million, -31.23% less than in 2023.